Señales en vivo de NBY | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 may 2024 @ 16:00):

Stats
Volumen de hoy	133.28M
Volumen promedio	5.07M
Capitalización de mercado	4.49M
EPS	$0 ( 2024-05-09 )
Próxima fecha de ganancias	( $-0.150 ) 2024-05-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0300
ATR14	$0.00100 (0.84%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-09	Freiman Paul E.	Buy	858	Restricted Stock Units
2023-06-09	Garlikov Julie	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yenyou	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yongxiang	Buy	858	Restricted Stock Units
2023-06-09	Sit Swan	Buy	858	Restricted Stock Units

INSIDER POWER
-62.74
Last 96 transactions
Buy: 2 335 940 \| Sell: 2 184 002

Volumen Correlación

Largo: -0.22 (neutral)

Corto: -0.16 (neutral)

Signal:(53.018) Neutral

NovaBay Pharmaceuticals Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NovaBay Pharmaceuticals Correlación - Moneda/Commodity

0.00
( neutral )

-0.45
( neutral )

0.00
( neutral )

0.79
( moderate )

NovaBay Pharmaceuticals Finanzas

Annual	2023
Ingresos:	$14.73M
Beneficio Bruto:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2023
Ingresos:	$14.73M
Beneficio Bruto:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2022
Ingresos:	$14.40M
Beneficio Bruto:	$7.78M (54.02 %)
EPS:	$-10.10

FY	2021
Ingresos:	$8.42M
Beneficio Bruto:	$5.65M (67.03 %)
EPS:	$-9.42

Financial Reports:

No articles found.

NovaBay Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.